Last reviewed · How we verify
Dexametasone
At a glance
| Generic name | Dexametasone |
|---|---|
| Also known as | Both groups received dexametasone |
| Sponsor | PETHEMA Foundation |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Management of Pain in Lumbar Arthrodesis (PHASE4)
- Prevention of Rebound Pain After Axillary Block (NA)
- The Effect of Dexamethasone in Full Pulpotomy on Postoperative Pain in Permanent Molars (NA)
- Dexamethasone Regimens for BPD Prevention in Preterm Infants (PHASE3)
- Intra-operative Steroid Irrigation for Reducing Recurrent Laryngeal Nerve Palsy Post-thyroidectomy (NA)
- Comparative Efficacy of IV Dexamethasone vs. Nebulized Salbutamol for Renal Colic Pain in the ED (PHASE3)
- A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse." (PHASE2)
- Comparison of Hyaluronidase and Dexametasone in Reduction of Postoperative Edema (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dexametasone CI brief — competitive landscape report
- Dexametasone updates RSS · CI watch RSS
- PETHEMA Foundation portfolio CI